JnJ Faulty Hip Implants: 7 more patients found fit for compensation Meghna A Singhania30 March 2019 1:15 PM ISTMumbai: Several patients who claim to be suffering due to faulty hip implants manufactured by Johnson and Johnson (JnJ) have been claiming...
Cancer Causing Talcum Powder: JnJ gets New Jersey jury relief Medical Dialogues Bureau29 March 2019 11:40 AM ISTJnJ on Wednesday also settled three other mesothelioma talc cases pending in state courts in California, Oklahoma and New York, Chris Panatier, a...
J&J passes asbestos test, allowed to make baby powder in India Farhat Nasim1 March 2019 2:28 PM ISTNEW DELHI: In a major relief to Johnson & Johnson(J&J), no asbestos was found in the baby powder manufactured in Baddi and Mulund plants. The...
Johnson and Johnson settles case in U.S for $120 million Farhat Nasim24 Jan 2019 10:55 AM ISTThe states claimed Johnson and Johnson made misleading claims about the longevity of its metal-on-metal hip implants, with patients frequently having...
Relief for J&J: Supreme court closes faulty hip implants case Farhat Nasim11 Jan 2019 10:00 AM ISTA bench comprising Chief Justice Ranjan Gogoi and Justice S K Kaul considered the response filed by the Union Health Ministry which said that a...
After damaging Reuters report, J&J doubles down on talc safety message Farhat Nasim1 Jan 2019 9:15 AM ISTTo reassure investors and consumers, J&J has tweeted, posted on Facebook, run a series of full-page newspaper ads across the United States,...
Another trouble for J&J: CDSCO seize samples of baby products for testing Farhat Nasim22 Dec 2018 12:14 PM ISTThe action by CDSCO has come at a time when the company is already embroiled in a controversy over its faulty hip implants. New Delhi: Following...
Asbestos scare: CDSCO draws samples of J&J baby powder from HP plant Medical Dialogues Bureau20 Dec 2018 5:12 PM ISTThe CDSCO, under the Union Health Ministry, said over the next four to five days, drug inspectors will search manufacturing plants and wholesalers of...
SGLT2 inhibitors can lead to serious genital infection: USFDA warning Ruby Khatun Khatun31 Aug 2018 4:50 PM ISTThe SGLT2 inhibitors approved by the FDA include Johnson and Johnson's Invokana, Eli Lilly & Co's Jardiance, as well as those from Bristol-Myers...
Bayer, Johnson and Johnson's heart drug Xarelto fails trial to widen use Ruby Khatun Khatun28 Aug 2018 9:45 AM ISTFRANKFURT: Bayer and Johnson and Johnson's campaign to widen the market for its heart drug Xarelto hit a snag on Sunday when a study for a potential...
OxyContin maker Purdue taps financial restructuring adviser - sources Ruby Khatun Khatun20 Aug 2018 9:45 AM ISTNEW YORK/BOSTON: OxyContin maker Purdue Pharma LP has tapped law firm Davis Polk & Wardwell LLP for financial restructuring advice, as its...
Cutting TB drugs prices in India: Johnson and Johnson, Mylan propose ways Ruby Khatun Khatun18 March 2018 3:51 PM ISTNew Delhi: To provide their Multidrug-Resistant (MDR) TB drugs at cheaper rates to TB patients in India so that patients could easily access to them...
